Back to search

France· FR:67322542

NIPENT 10 mg, poudre pour solution pour injection, poudre pour solution pour perfusion

A pentostatin product containing pentostatine, registered in France by PFIZER HOLDING FRANCE. The same ATC class is registered in 5 of our 19 countries.

ATC L01XX08

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNIPENT 10 mg, poudre pour solution po…ATCL01XX08REGISTER NO.FR:67322542PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Pentostatin is registered in 5 of 19 countries.

Countries holding a registration under ATC L01XX08 (pentostatin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 2 of them publish a price we can compare per daily dose

Pentostatin · ATC L01XX08

5 / 19 countries

  • Franceprice
  • Germany
  • Ireland
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PENTOSTATINE
Manufacturer
PFIZER HOLDING FRANCE
Country
France (FR)
ATC code
L01XX08
ATC class
Pentostatin
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955804109
    1 flacon(s) en verre de 10 mg

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

130 interactions on record for pentostatin.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pentostatin · interactions on record

130 records

  • 31 severe
  • 83 moderate
  • 16 minor

Most severe, free to view

  • CladribineL01BB04severe
  • FludarabineL01BB05severe
  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pentostatin in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pentostatin products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Germany · Nipent
  • Spain · Nipent
  • United Kingdom (Northern Ireland) · Nipent
  • Greece · Nipent
  • Ireland · Nipent
  • Italy · Nipent
  • Malta · Nipent
  • Portugal · Nipent

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0f3a8baa-d3db-4d3b-8adf-cdd3e8516ac5
GET /v1/drugs/0f3a8baa-d3db-4d3b-8adf-cdd3e8516ac5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67322542",
  "date_amm": "1993-03-25",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "PENTOSTATINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution pour injection ou pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about pentostatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.